Leprosy Mailing List – June 10, 2018
Ref.: (LML) Single-dose rifampicin chemoprophylaxis
From: Ben Naafs, Munnekeburen, the Netherlands
Dear Pieter
Some time ago, Dr. Diana Lockwood ask for comments concerning Single-dose rifampicin (SDR) chemoprphylaxis in a letter to LML.
Recently, the following article was published: Lockwood DNJ, Krishnamurthy P, Kumar B, Penna G (2018) Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention. PLoS Negl Trop Dis 12(6): e0006403. https://doi.org/10.1371/journal.pntd.0006403
http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006403
We strongly recommend reading this publication. It is important that we as leprologists keep reviewing leprosy control policies critically.
Regards,
Ben
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
No comments:
Post a Comment